KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 137 filers reported holding KRYSTAL BIOTECH INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,675,472 | +5.7% | 117,892 | +7.0% | 1.26% | -12.2% |
| Q2 2023 | $12,936,541 | +89.7% | 110,192 | +29.4% | 1.44% | +103.7% |
| Q1 2023 | $6,819,431 | -54.3% | 85,179 | -54.7% | 0.71% | -67.0% |
| Q4 2022 | $14,910,551 | +3.2% | 188,217 | -9.2% | 2.14% | +8.9% |
| Q3 2022 | $14,451,000 | +2.6% | 207,332 | -3.3% | 1.96% | -10.6% |
| Q2 2022 | $14,083,000 | -26.8% | 214,482 | -25.9% | 2.20% | -11.6% |
| Q1 2022 | $19,252,000 | +20.5% | 289,337 | +26.7% | 2.48% | +55.2% |
| Q4 2021 | $15,979,000 | +143.8% | 228,437 | +82.0% | 1.60% | +56.7% |
| Q3 2021 | $6,554,000 | +42.7% | 125,529 | +85.9% | 1.02% | +44.6% |
| Q2 2021 | $4,592,000 | -64.3% | 67,529 | -59.5% | 0.71% | -69.5% |
| Q1 2021 | $12,854,000 | +1956.6% | 166,844 | +1500.7% | 2.32% | +2724.4% |
| Q4 2020 | $625,000 | – | 10,423 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 771,250 | $53,949,000 | 4.15% |
| First Light Asset Management, LLC | 680,170 | $47,578,000 | 3.41% |
| ACT CAPITAL MANAGEMENT, LLC | 59,000 | $4,127,000 | 2.98% |
| S Squared Technology, LLC | 95,215 | $6,660,000 | 2.98% |
| Redmile Group, LLC | 1,820,898 | $127,372,000 | 2.90% |
| Soleus Capital Management, L.P. | 228,437 | $15,979,000 | 1.60% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 50,922 | $3,562,000 | 1.59% |
| Artal Group S.A. | 700,000 | $48,965,000 | 1.33% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 46,670 | $3,265,000 | 1.32% |
| Kynam Capital Management, LP | 34,816 | $2,435,000 | 1.30% |